PACBPacific Biosciences of California, Inc.
$2.30+64% 1Y
$2.30
$1.1152 weeks$2.88
Is the price fair?
What PACB's price assumes
Pacific Biosciences of California, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2.52× revenue.
2.52
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 171
Price / book · as of 2026-Q1
Details›
- Price / bookas of 2026-Q1
- 171
- Market capitalisation
- $714M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.